Coronavirus Drug Trial

DGCI okays Itolizumab drug for restricted emergency use on COVID patients

Biocon, a domestic biopharmaceutical company, has been manufacturing and marketing the drug.

Hydroxychloroquine study for coronavirus partly stopped as patients develop heart complications

One-fourth of those assigned to get 600 milligrams twice a day for 10 days developed heart rhythm problems, and trends suggested more deaths

Japan gives the go-ahead to test Fujifilm's anti-flu drug Avigan in fight against coronavirus

Trials in China have suggested Avigan could play a role in shortening the recovery time for patients infected with coronavirus.

1 of 1